Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Helius Medical Technologies Inc
(NQ:
HSDT
)
0.5650
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Helius Medical Technologies Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
March 09, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms from Stroke
March 09, 2023
-- PoNS already approved in Canada for treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury (TBI) and gait deficit due to mild and moderate symptoms from Multiple...
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Earnings Preview For Helius Medical Tech
March 08, 2023
Via
Benzinga
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
March 06, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Looking Into Helius Medical Tech's Return On Capital Employed
December 23, 2022
Via
Benzinga
Helius Medical Technologies to Present at the 35th Annual ROTH Conference
March 02, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies to Showcase PoNS Therapy™ at American Physical Therapy Association’s 2023 Combined Sections Meeting
February 15, 2023
Physical therapists in attendance can enhance their skillset with free on-site PoNS training
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
January 23, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023
January 19, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program
January 10, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis
January 05, 2023
PTAP Lowers the Cost of PoNS Therapy™ for Qualified Americans
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk
January 03, 2023
New Partnership with UpScript Provides Access to Care, Delivers PoNS Devices to Doorsteps
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
December 30, 2022
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 22, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Thursday!
Via
InvestorPlace
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares rose 77.7% to $0.0906 in pre-market trading. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 21, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
December 20, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 02, 2022
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Friday morning!
Via
InvestorPlace
Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket
November 25, 2022
Gainers VEON Ltd. (NASDAQ: VEON) shares rose 31.1% to $0.6095 in pre-market trading after the company agreed to sell its Russian business, Vimpelcom for 130 billion roubles ($2.2 billion).
Via
Benzinga
Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results
November 14, 2022
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
November 17, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
Via
Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...
Via
Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 14, 2022
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
Via
Benzinga
Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience Program
November 09, 2022
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program
November 08, 2022
-- Third Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects’ adherence to PoNS® therapy for gait improvement...
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait
November 03, 2022
Physical Therapists Who Visit Booth 512 Can Sign Up for Free Online PoNS Therapy™ Training
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. to Release Third Quarter 2022 Financial Results on November 14, 2022
November 01, 2022
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Salutes Physical Therapists for Their Role in Helping People with MS Improve Their Gait
October 13, 2022
Company Spotlights its Appreciation to Physical Therapists Trained in its Innovative PoNS Therapy™ in Honor of National Physical Therapy Month
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 11, 2022
Good morning, trader! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.